Advances in the use of tocols as drug delivery vehicles

被引:110
作者
Constantinides, PP
Han, JH
Davis, SS
机构
[1] Biopharmaceut & Drug Delivery Consulting LLC, Gurnee, IL 60031 USA
[2] Univ London, Sch Pharm, Ctr Paediat Pharm Res, London WC1N 1AX, England
[3] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England
关键词
bioavailability enhancement; tocol chemistry; drug solubilization; oral; parenteral drug delivery; P-glycoprotein inhibition; tocols; topical;
D O I
10.1007/s11095-005-9262-9
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
There has been increasing interest in recent years in the drug delivery applications of tocols and their derivatives. Their biocompatibility and potential to deliver both poorly soluble and water-soluble drugs make tocols attractive as drug delivery vehicles. This review article will focus primarily on topical, oral, and parenteral drug administration using tocols, although other routes of delivery such as pulmonary and nasal will also be discussed. After an overview of the tocol structures, physicochemical properties with emphasis on their solvent properties, functions, and metabolism, specific case studies will be discussed where tocols have been successfully used in topical, oral, and parenteral drug formulations and marketed drug products. Case studies will be extended to those where tocol-based formulations were administered pulmonarily and nasally. As more clinical data and marketed drug products emerge, the utility and therapeutic value of tocols will certainly increase.
引用
收藏
页码:243 / 255
页数:13
相关论文
共 98 条
[1]  
ALADE SL, 1986, PEDIATRICS, V77, P593
[2]   Micelles of methoxy poly(ethylene oxide)-b-poly(ε-caprolactone) as vehicles for the solubilization and controlled delivery of Cyclosporine A [J].
Aliabadi, HM ;
Mahmud, A ;
Sharifabadi, AD ;
Lavasanifar, A .
JOURNAL OF CONTROLLED RELEASE, 2005, 104 (02) :301-311
[3]   Nanomedicines for overcoming biological barriers [J].
Alonso, MJ .
BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (03) :168-172
[4]   Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers [J].
Alsenz, J ;
Steffen, H ;
Alex, R .
PHARMACEUTICAL RESEARCH, 1998, 15 (03) :423-428
[5]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[6]  
[Anonymous], 1999, Pharm. Technol
[7]  
[Anonymous], 1993, VITAMIN HLTH DIS
[8]  
ARROWSMITH JB, 1989, PEDIATRICS, V83, P244
[9]   Vitamin E deficiency induced neurological disease in common variable immunodeficiency: two cases and a review of the literature of vitamin E deficiency [J].
Aslam, A ;
Misbah, SA ;
Talbot, K ;
Chapel, H .
CLINICAL IMMUNOLOGY, 2004, 112 (01) :24-29
[10]   Pilot study on the effect of parenteral vitamin E on ischemia and reperfusion induced liver injury: a double blind, randomized, placebo-controlled trial [J].
Bartels, M ;
Biesatski, HK ;
Engelhart, K ;
Sendlhofer, G ;
Rehak, P ;
Nagel, E .
CLINICAL NUTRITION, 2004, 23 (06) :1360-1370